
Senior Scientist, Safety & Exploratory Pharmacology
Merck
Summary
The Nonclinical Drug Safety (NDS) division is seeking a motivated and talented integrative systems pharmacologist/physiologist with functional and strategic experience in nonclinical risk assessment to join the Safety & Exploratory Pharmacology group.
Job description
The Safety & Exploratory Pharmacology (SEP) group utilizes a purposeful blend of standard screening tools, regulatory-enabling assays, fit for purpose capabilities and forward-looking innovative solutions to understand potential major organ system pharmacodynamic risk to influence drug development strategy.
We are looking for an individual contributor that will complement existing areas and expand the team's expertise to enable drug discovery and development and drive future innovation that influence the external scientific and regulatory communities.
Education
- PhD or DVM in Pharmacology, Toxicology or related field with 0-5 years relevant experience
- MS in Pharmacology, Toxicology or related field with 3 or more years relevant experience
- BS in Pharmacology, Toxicology or related field with 7 or more years relevant experience
Required Experience And Skills
- Ability to work within teams as a contributor and/or as a team lead to drive collaborations across departments that deliver current needs and future capabilities
- Development, execution and interpretation of exploratory or regulated nonclinical safety pharmacology/toxicology models
- Experience with nonclinical physiologic data acquisition and analysis with experience in electrocardiogram interval &/or ECG morphology analysis
- Experience in other critical organ systems such as neurobehavioral, respiratory would be additional considerations
- Experience either as a study director or contributing scientist for studies conducted under Good Laboratory Practices (GLP) that utilize common nonclinical test systems
Preferred Experience And Skills
- Prior experience working in a multidisciplinary environment within the Pharmaceutical Industry, Regulatory Agencies, or Academic Institutions
- Development and/or utilization of exploratory safety pharmacology models to enable issue-driven resolution to advance drug development
- Experience or familiarity with biostatistics and/or data visualization tools
Requirements
- PhD or DVM in Pharmacology, Toxicology or related field with 0-5 years relevant experience
- MS in Pharmacology, Toxicology or related field with 3 or more years relevant experience
- BS in Pharmacology, Toxicology or related field with 7 or more years relevant experience
- Ability to work within teams as a contributor and/or as a team lead to drive collaborations across departments
- Development, execution and interpretation of exploratory or regulated nonclinical safety pharmacology/toxicology models
- Experience with nonclinical physiologic data acquisition and analysis
- Experience in electrocardiogram interval &/or ECG morphology analysis
- Experience as a study director or contributing scientist for studies conducted under Good Laboratory Practices (GLP)
- Experience with common nonclinical test systems
- Data Visualization Tools
- Electrocardiography (EKG)
- Good Lab Practices
- In Vivo Models
- Mechanism of Action Studies
- Pharmacology
- Safety Pharmacology
- Systems Physiology
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation
- Compassionate Leave
- Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.